APPLE INC., 10-Q filed on 5/1/2026
Quarterly Report
v3.26.1
Cover Page - shares
shares in Thousands
6 Months Ended
Mar. 28, 2026
Apr. 17, 2026
Entity Information [Line Items]    
Document Type 10-Q  
Document Quarterly Report true  
Document Period End Date Mar. 28, 2026  
Document Transition Report false  
Entity File Number 001-36743  
Entity Registrant Name Apple Inc.  
Entity Incorporation, State or Country Code CA  
Entity Tax Identification Number 94-2404110  
Entity Address, Address Line One One Apple Park Way  
Entity Address, City or Town Cupertino  
Entity Address, State or Province CA  
Entity Address, Postal Zip Code 95014  
City Area Code 408  
Local Phone Number 996-1010  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Large Accelerated Filer  
Entity Small Business false  
Entity Emerging Growth Company false  
Entity Shell Company false  
Entity Common Stock, Shares Outstanding (in shares)   14,687,356
Amendment Flag false  
Document Fiscal Year Focus 2026  
Document Fiscal Period Focus Q2  
Entity Central Index Key 0000320193  
Current Fiscal Year End Date --09-26  
Common Stock, $0.00001 par value per share    
Entity Information [Line Items]    
Title of 12(b) Security Common Stock, $0.00001 par value per share  
Trading Symbol AAPL  
Security Exchange Name NASDAQ  
1.625% Notes due 2026    
Entity Information [Line Items]    
Title of 12(b) Security 1.625% Notes due 2026  
No Trading Symbol Flag true  
Security Exchange Name NASDAQ  
2.000% Notes due 2027    
Entity Information [Line Items]    
Title of 12(b) Security 2.000% Notes due 2027  
No Trading Symbol Flag true  
Security Exchange Name NASDAQ  
1.375% Notes due 2029    
Entity Information [Line Items]    
Title of 12(b) Security 1.375% Notes due 2029  
No Trading Symbol Flag true  
Security Exchange Name NASDAQ  
3.050% Notes due 2029    
Entity Information [Line Items]    
Title of 12(b) Security 3.050% Notes due 2029  
No Trading Symbol Flag true  
Security Exchange Name NASDAQ  
0.500% Notes due 2031    
Entity Information [Line Items]    
Title of 12(b) Security 0.500% Notes due 2031  
No Trading Symbol Flag true  
Security Exchange Name NASDAQ  
3.600% Notes due 2042    
Entity Information [Line Items]    
Title of 12(b) Security 3.600% Notes due 2042  
No Trading Symbol Flag true  
Security Exchange Name NASDAQ  
v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) - USD ($)
shares in Thousands, $ in Millions
3 Months Ended 6 Months Ended
Mar. 28, 2026
Mar. 29, 2025
Mar. 28, 2026
Mar. 29, 2025
Net sales $ 111,184 $ 95,359 $ 254,940 $ 219,659
Cost of sales 56,403 50,492 130,928 116,517
Gross margin 54,781 44,867 124,012 103,142
Operating expenses:        
Research and development 11,419 8,550 22,306 16,818
Selling, general and administrative 7,477 6,728 14,969 13,903
Total operating expenses 18,896 15,278 37,275 30,721
Operating income 35,885 29,589 86,737 72,421
Other income/(expense), net (52) (279) 98 (527)
Income before provision for income taxes 35,833 29,310 86,835 71,894
Provision for income taxes 6,255 4,530 15,160 10,784
Net income $ 29,578 $ 24,780 $ 71,675 $ 61,110
Earnings per share:        
Basic (in dollars per share) $ 2.02 $ 1.65 $ 4.87 $ 4.06
Diluted (in dollars per share) $ 2.01 $ 1.65 $ 4.85 $ 4.05
Shares used in computing earnings per share:        
Basic (in shares) 14,673,278 14,994,082 14,710,718 15,037,903
Diluted (in shares) 14,725,873 15,056,133 14,768,115 15,103,499
Products        
Net sales $ 80,208 $ 68,714 $ 193,951 $ 166,674
Cost of sales 49,179 44,030 116,657 103,477
Services        
Net sales 30,976 26,645 60,989 52,985
Cost of sales $ 7,224 $ 6,462 $ 14,271 $ 13,040
v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (Unaudited) - USD ($)
$ in Millions
3 Months Ended 6 Months Ended
Mar. 28, 2026
Mar. 29, 2025
Mar. 28, 2026
Mar. 29, 2025
Statement of Comprehensive Income [Abstract]        
Net income $ 29,578 $ 24,780 $ 71,675 $ 61,110
Other comprehensive income/(loss):        
Change in foreign currency translation, net of tax 67 90 (92) (535)
Change in unrealized gains/losses on derivative instruments, net of tax:        
Change in fair value of derivative instruments 162 (318) 373 1,333
Adjustment for net (gains)/losses realized and included in net income 44 (628) 281 156
Total change in unrealized gains/losses on derivative instruments 206 (946) 654 1,489
Change in unrealized gains/losses on marketable debt securities, net of tax:        
Change in fair value of marketable debt securities (808) 1,097 (384) (550)
Adjustment for net (gains)/losses realized and included in net income 14 185 18 405
Total change in unrealized gains/losses on marketable debt securities (794) 1,282 (366) (145)
Other comprehensive income/(loss) (521) 426 196 809
Total comprehensive income $ 29,057 $ 25,206 $ 71,871 $ 61,919
v3.26.1
CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) - USD ($)
$ in Millions
Mar. 28, 2026
Sep. 27, 2025
Current assets:    
Cash and cash equivalents $ 45,572 $ 35,934
Marketable securities 22,935 18,763
Accounts receivable, net 30,339 39,777
Vendor non-trade receivables 23,172 33,180
Inventories 6,747 5,718
Other current assets 15,349 14,585
Total current assets 144,114 147,957
Non-current assets:    
Marketable securities 78,088 77,723
Property, plant and equipment, net 50,116 49,834
Intangible assets, net 21,334 11,093
Other non-current assets 77,430 72,634
Total non-current assets 226,968 211,284
Total assets 371,082 359,241
Current liabilities:    
Accounts payable 57,349 69,860
Other current liabilities 57,654 66,387
Deferred revenue 9,331 9,055
Commercial paper 1,997 7,979
Term debt 8,310 12,350
Total current liabilities 134,641 165,631
Non-current liabilities:    
Term debt 74,404 78,328
Other non-current liabilities 55,546 41,549
Total non-current liabilities 129,950 119,877
Total liabilities 264,591 285,508
Commitments and contingencies
Shareholders’ equity:    
Common stock and additional paid-in capital, $0.00001 par value: 50,400,000 shares authorized; 14,667,688 and 14,773,260 shares issued and outstanding, respectively 99,507 93,568
Retained earnings/(Accumulated deficit) 12,359 (14,264)
Accumulated other comprehensive loss (5,375) (5,571)
Total shareholders’ equity 106,491 73,733
Total liabilities and shareholders’ equity $ 371,082 $ 359,241
v3.26.1
CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (Parenthetical) - $ / shares
Mar. 28, 2026
Sep. 27, 2025
Statement of Financial Position [Abstract]    
Common stock, par value (in dollars per share) $ 0.00001 $ 0.00001
Common stock, shares authorized (in shares) 50,400,000,000 50,400,000,000
Common stock, shares issued (in shares) 14,667,688,000 14,773,260,000
Common stock, shares outstanding (in shares) 14,667,688,000 14,773,260,000
v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY (Unaudited) - USD ($)
$ in Millions
Total
Common stock and additional paid-in capital
Retained earnings/(Accumulated deficit)
Accumulated other comprehensive income/(loss)
Beginning balances at Sep. 28, 2024 $ 56,950 $ 83,276 $ (19,154) $ (7,172)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Common stock issued   825    
Common stock withheld related to net share settlement of equity awards   (2,097) (1,187)  
Share-based compensation   6,707    
Net income 61,110   61,110  
Dividends and dividend equivalents declared     (7,613)  
Common stock repurchased     (48,708)  
Other comprehensive income/(loss) 809     809
Ending balances at Mar. 29, 2025 $ 66,796 88,711 (15,552) (6,363)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Dividends and dividend equivalents declared per share or RSU (in dollars per share or RSU) $ 0.50      
Beginning balances at Dec. 28, 2024 $ 66,758 84,768 (11,221) (6,789)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Common stock issued   825    
Common stock withheld related to net share settlement of equity awards   (206) (85)  
Share-based compensation   3,324    
Net income 24,780   24,780  
Dividends and dividend equivalents declared     (3,794)  
Common stock repurchased     (25,232)  
Other comprehensive income/(loss) 426     426
Ending balances at Mar. 29, 2025 $ 66,796 88,711 (15,552) (6,363)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Dividends and dividend equivalents declared per share or RSU (in dollars per share or RSU) $ 0.25      
Beginning balances at Sep. 27, 2025 $ 73,733 93,568 (14,264) (5,571)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Common stock issued   878    
Common stock withheld related to net share settlement of equity awards   (2,308) (1,024)  
Share-based compensation   7,369    
Net income 71,675   71,675  
Dividends and dividend equivalents declared     (7,735)  
Common stock repurchased (36,000)   (36,293)  
Other comprehensive income/(loss) 196     196
Ending balances at Mar. 28, 2026 $ 106,491 99,507 12,359 (5,375)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Dividends and dividend equivalents declared per share or RSU (in dollars per share or RSU) $ 0.52      
Beginning balances at Dec. 27, 2025 $ 88,190 95,221 (2,177) (4,854)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Common stock issued   878    
Common stock withheld related to net share settlement of equity awards   (250) (88)  
Share-based compensation   3,658    
Net income 29,578   29,578  
Dividends and dividend equivalents declared     (3,855)  
Common stock repurchased     (11,099)  
Other comprehensive income/(loss) (521)     (521)
Ending balances at Mar. 28, 2026 $ 106,491 $ 99,507 $ 12,359 $ (5,375)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Dividends and dividend equivalents declared per share or RSU (in dollars per share or RSU) $ 0.26      
v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)
$ in Millions
6 Months Ended
Mar. 28, 2026
Mar. 29, 2025
Statement of Cash Flows [Abstract]    
Cash, cash equivalents, and restricted cash and cash equivalents, beginning balances $ 35,934 $ 29,943
Operating activities:    
Net income 71,675 61,110
Adjustments to reconcile net income to cash generated by operating activities:    
Depreciation and amortization 6,653 5,741
Share-based compensation expense 7,122 6,512
Other (1,717) (2,217)
Changes in operating assets and liabilities:    
Accounts receivable, net 9,295 7,266
Vendor non-trade receivables 10,008 9,171
Inventories (1,084) 858
Other current and non-current assets (14,329) (4,371)
Accounts payable (12,297) (14,604)
Other current and non-current liabilities 7,301 (15,579)
Cash generated by operating activities 82,627 53,887
Investing activities:    
Purchases of marketable securities (32,432) (12,442)
Proceeds from maturities of marketable securities 18,691 26,587
Proceeds from sales of marketable securities 8,615 5,210
Payments for acquisition of property, plant and equipment (4,344) (6,011)
Other (1,584) (635)
Cash generated by/(used in) investing activities (11,054) 12,709
Financing activities:    
Payments for taxes related to net share settlement of equity awards (3,252) (3,205)
Payments for dividends and dividend equivalents (7,743) (7,614)
Repurchases of common stock (36,989) (49,504)
Repayments of term debt (7,914) (4,009)
Total repayments of commercial paper, net (5,911) (3,968)
Other (126) (77)
Cash used in financing activities (61,935) (68,377)
Increase/(Decrease) in cash, cash equivalents, and restricted cash and cash equivalents 9,638 (1,781)
Cash, cash equivalents, and restricted cash and cash equivalents, ending balances 45,572 28,162
Supplemental cash flow disclosure:    
Cash paid for income taxes, net $ 20,397 $ 31,683
v3.26.1
Summary of Significant Accounting Policies
6 Months Ended
Mar. 28, 2026
Accounting Policies [Abstract]  
Summary of Significant Accounting Policies Summary of Significant Accounting Policies
Basis of Presentation and Preparation
The condensed consolidated financial statements include the accounts of Apple Inc. and its wholly owned subsidiaries (collectively “Apple” or the “Company”). In the opinion of the Company’s management, the condensed consolidated financial statements reflect all adjustments, which are normal and recurring in nature, necessary for fair financial statement presentation. The preparation of these condensed consolidated financial statements and accompanying notes in conformity with U.S. generally accepted accounting principles (“GAAP”) requires the use of management estimates. Certain prior period amounts in the condensed consolidated financial statements and accompanying notes have been reclassified to conform to the current period’s presentation. These condensed consolidated financial statements and accompanying notes should be read in conjunction with the Company’s annual consolidated financial statements and accompanying notes included in its Annual Report on Form 10-K for the fiscal year ended September 27, 2025 (the “2025 Form 10-K”).
The Company’s fiscal year is the 52- or 53-week period that ends on the last Saturday of September. An additional week is included in the first fiscal quarter every five or six years to realign the Company’s fiscal quarters with calendar quarters. The Company’s fiscal years 2026 and 2025 span 52 weeks each. Unless otherwise stated, references to particular years, quarters, months and periods refer to the Company’s fiscal years ended in September and the associated quarters, months and periods of those fiscal years.
v3.26.1
Revenue
6 Months Ended
Mar. 28, 2026
Revenue from Contract with Customer [Abstract]  
Revenue Revenue
The following table shows disaggregated net sales, as well as the portion of total net sales that was previously deferred, for the three- and six-month periods ended March 28, 2026 and March 29, 2025 (in millions):
Three Months EndedSix Months Ended
March 28,
2026
March 29,
2025
March 28,
2026
March 29,
2025
iPhone®
$56,994 $46,841 $142,263 $115,979 
Mac®
8,399 7,949 16,785 16,936 
iPad®
6,914 6,402 15,509 14,490 
Wearables, Home and Accessories7,901 7,522 19,394 19,269 
Services30,976 26,645 60,989 52,985 
Total net sales$111,184 $95,359 $254,940 $219,659 
Portion of total net sales that was included in deferred revenue as of the beginning of the period
$3,987 $3,672 $5,834 $5,440 
The Company’s proportion of net sales by disaggregated revenue source was generally consistent for each reportable segment in Note 10, “Segment Information” for the three- and six-month periods ended March 28, 2026 and March 29, 2025, except in Greater China, where iPhone revenue represented a moderately higher proportion of net sales.
As of March 28, 2026 and September 27, 2025, the Company had total deferred revenue of $14.7 billion and $13.7 billion, respectively. As of March 28, 2026, the Company expects 64% of total deferred revenue to be realized in less than a year, 23% within one-to-two years, 11% within two-to-three years and 2% in greater than three years.
v3.26.1
Earnings Per Share
6 Months Ended
Mar. 28, 2026
Earnings Per Share [Abstract]  
Earnings Per Share Earnings Per Share
The following table shows the computation of basic and diluted earnings per share for the three- and six-month periods ended March 28, 2026 and March 29, 2025 (net income in millions and shares in thousands):
Three Months EndedSix Months Ended
March 28,
2026
March 29,
2025
March 28,
2026
March 29,
2025
Numerator:
Net income$29,578 $24,780 $71,675 $61,110 
Denominator:
Weighted-average basic shares outstanding14,673,278 14,994,082 14,710,718 15,037,903 
Effect of dilutive share-based awards
52,595 62,051 57,397 65,596 
Weighted-average diluted shares14,725,873 15,056,133 14,768,115 15,103,499 
Basic earnings per share$2.02 $1.65 $4.87 $4.06 
Diluted earnings per share$2.01 $1.65 $4.85 $4.05 
v3.26.1
Financial Instruments
6 Months Ended
Mar. 28, 2026
Financial Instruments [Abstract]  
Financial Instruments Financial Instruments
Cash, Cash Equivalents and Marketable Securities
The following tables show the Company’s cash, cash equivalents and marketable securities by significant investment category as of March 28, 2026 and September 27, 2025 (in millions):
March 28, 2026
Adjusted
Cost
Unrealized
Gains
Unrealized
Losses
Fair
Value
Cash and
Cash
Equivalents
Current
Marketable
Securities
Non-Current
Marketable
Securities
Cash$29,740 $— $— $29,740 $29,740 $— $— 
Level 1:
Money market funds6,588 — — 6,588 6,588 — — 
Mutual funds
821 128 (14)935 — 935 — 
Subtotal7,409 128 (14)7,523 6,588 935 — 
Level 2 (1):
U.S. Treasury securities18,650 14 (254)18,410 2,935 4,174 11,301 
U.S. agency securities7,483 — (112)7,371 2,923 2,470 1,978 
Non-U.S. government securities5,906 45 (493)5,458 — 576 4,882 
Certificates of deposit and time deposits3,263 — — 3,263 2,987 276 — 
Commercial paper3,628 — — 3,628 399 3,229 — 
Corporate debt securities48,111 83 (982)47,212 — 11,042 36,170 
Municipal securities122 — (1)121 — 95 26 
Mortgage- and asset-backed securities25,106 64 (1,301)23,869 — 138 23,731 
Subtotal112,269 206 (3,143)109,332 9,244 22,000 78,088 
Total
$149,418 $334 $(3,157)$146,595 $45,572 $22,935 $78,088 
September 27, 2025
Adjusted
Cost
Unrealized
Gains
Unrealized
Losses
Fair
Value
Cash and
Cash
Equivalents
Current
Marketable
Securities
Non-Current
Marketable
Securities
Cash$28,267 $— $— $28,267 $28,267 $— $— 
Level 1:
Money market funds5,272 — — 5,272 5,272 — — 
Mutual funds
679 177 (2)854 — 854 — 
Subtotal5,951 177 (2)6,126 5,272 854 — 
Level 2 (1):
U.S. Treasury securities16,074 56 (282)15,848 1,190 3,712 10,946 
U.S. agency securities5,269 — (149)5,120 251 2,456 2,413 
Non-U.S. government securities6,586 111 (424)6,273 — 855 5,418 
Certificates of deposit and time deposits917 — — 917 904 — 13 
Commercial paper100 — — 100 50 50 — 
Corporate debt securities47,210 266 (916)46,560 — 10,623 35,937 
Municipal securities207 — (2)205 — 119 86 
Mortgage- and asset-backed securities24,130 126 (1,252)23,004 — 94 22,910 
Subtotal100,493 559 (3,025)98,027 2,395 17,909 77,723 
Total
$134,711 $736 $(3,027)$132,420 $35,934 $18,763 $77,723 
(1)The valuation techniques used to measure the fair values of the Company’s Level 2 financial instruments, which generally have counterparties with high credit ratings, are based on quoted market prices or model-driven valuations using significant inputs derived from or corroborated by observable market data.
As of March 28, 2026, 79% of the Company’s non-current marketable debt securities other than mortgage- and asset-backed securities had maturities between 1 and 5 years, 17% between 5 and 10 years, and 4% greater than 10 years. As of March 28, 2026, 13% of the Company’s non-current mortgage- and asset-backed securities had maturities between 1 and 5 years, 22% between 5 and 10 years, and 65% greater than 10 years.
Derivative Instruments and Hedging
The Company may use derivative instruments to partially offset its business exposure to foreign exchange and interest rate risk. However, the Company may choose not to hedge certain exposures for a variety of reasons, including accounting considerations or the prohibitive economic cost of hedging particular exposures. There can be no assurance the hedges will offset more than a portion of the financial impact resulting from movements in foreign exchange or interest rates.
Foreign Exchange Rate Risk
To protect gross margins from fluctuations in foreign exchange rates, the Company may use forwards, options or other instruments, and may designate these instruments as cash flow hedges. The Company generally hedges portions of its forecasted foreign currency exposure associated with revenue and inventory purchases, typically for up to 12 months.
To protect the Company’s foreign currency–denominated term debt or marketable securities from fluctuations in foreign exchange rates, the Company may use forwards, cross-currency swaps or other instruments. The Company designates these instruments as either cash flow or fair value hedges. As of March 28, 2026, the maximum length of time over which the Company is hedging its exposure to the variability in future cash flows for term debt–related foreign currency transactions is 16 years.
The Company may also use derivative instruments that are not designated as accounting hedges to protect gross margins from certain fluctuations in foreign exchange rates, as well as to offset a portion of the foreign currency gains and losses generated by the remeasurement of certain assets and liabilities denominated in non-functional currencies.
Interest Rate Risk
To protect the Company’s term debt or marketable securities from fluctuations in interest rates, the Company may use interest rate swaps, options or other instruments. The Company designates these instruments as either cash flow or fair value hedges.
The notional amounts of the Company’s outstanding derivative instruments as of March 28, 2026 and September 27, 2025, were as follows (in millions):
March 28,
2026
September 27,
2025
Derivative instruments designated as accounting hedges:
Foreign exchange contracts$57,963 $62,647 
Interest rate contracts$10,625 $12,875 
Derivative instruments not designated as accounting hedges:
Foreign exchange contracts$96,341 $109,079 
As of March 28, 2026 and September 27, 2025, the carrying amount of the Company’s current and non-current term debt subject to fair value hedges was $10.4 billion and $12.6 billion, respectively.
Accounts Receivable
Trade Receivables
As of both March 28, 2026 and September 27, 2025, the Company had one customer that represented 10% or more of total trade receivables, which accounted for 17% and 12%, respectively. The Company’s third-party cellular network carriers accounted for 30% and 34% of total trade receivables as of March 28, 2026 and September 27, 2025, respectively. The Company requires third-party credit support or collateral from certain customers to limit credit risk.
Vendor Non-Trade Receivables
The Company has non-trade receivables from certain of its manufacturing vendors resulting from the sale of components to these vendors who manufacture subassemblies or assemble final products for the Company. The Company purchases these components directly from suppliers. The Company does not reflect the sale of these components in products net sales. Rather, the Company recognizes any gain on these sales as a reduction of products cost of sales when the related final products are sold by the Company. As of March 28, 2026, the Company had two vendors that individually represented 10% or more of total vendor non-trade receivables, which accounted for 51% and 18%. As of September 27, 2025, the Company had two vendors that individually represented 10% or more of total vendor non-trade receivables, which accounted for 46% and 23%.
v3.26.1
Condensed Consolidated Financial Statement Details
6 Months Ended
Mar. 28, 2026
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Condensed Consolidated Financial Statement Details Condensed Consolidated Financial Statement Details
The following tables show the Company’s condensed consolidated financial statement details as of March 28, 2026 and September 27, 2025 (in millions):
Property, Plant and Equipment, Net
March 28,
2026
September 27,
2025
Gross property, plant and equipment$127,557 $125,848 
Accumulated depreciation
(77,441)(76,014)
Total property, plant and equipment, net$50,116 $49,834 
Intangible Assets, Net
March 28,
2026
September 27,
2025
Gross intangible assets$37,767 $24,950 
Accumulated amortization(11,970)(11,649)
Total intangible assets, net25,797 13,301 
Less: Current portion of intangible assets, net(4,463)(2,208)
Non-current portion of intangible assets, net$21,334 $11,093 
v3.26.1
Debt
6 Months Ended
Mar. 28, 2026
Debt Disclosure [Abstract]  
Debt Debt
Commercial Paper
The Company issues unsecured short-term promissory notes pursuant to a commercial paper program. The Company uses net proceeds from the commercial paper program for general corporate purposes, including dividends and share repurchases. As of March 28, 2026 and September 27, 2025, the Company had $2.0 billion and $8.0 billion of commercial paper outstanding, respectively. The following table provides a summary of cash flows associated with commercial paper for the six months ended March 28, 2026 and March 29, 2025 (in millions):
Six Months Ended
March 28,
2026
March 29,
2025
Maturities 90 days or less:
Repayments of commercial paper, net$(2,123)$(3,968)
Maturities greater than 90 days:
Repayments of commercial paper(3,788)— 
Total repayments of commercial paper, net$(5,911)$(3,968)
Term Debt
As of March 28, 2026 and September 27, 2025, the Company had outstanding fixed-rate notes with varying maturities for an aggregate carrying amount of $82.7 billion and $90.7 billion, respectively (collectively the “Notes”). As of March 28, 2026 and September 27, 2025, the fair value of the Company’s Notes, based on Level 2 inputs, was $70.8 billion and $80.4 billion, respectively.
v3.26.1
Shareholders' Equity
6 Months Ended
Mar. 28, 2026
Equity [Abstract]  
Shareholders' Equity Shareholders’ Equity
Share Repurchase Program
During the six months ended March 28, 2026, the Company repurchased 135 million shares of its common stock for $36.0 billion. The Company’s share repurchase program does not obligate the Company to acquire a minimum amount of shares. Under the program, shares may be repurchased in privately negotiated or open market transactions, including under plans complying with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended (“Exchange Act”).
v3.26.1
Share-Based Compensation
6 Months Ended
Mar. 28, 2026
Share-Based Payment Arrangement [Abstract]  
Share-Based Compensation Share-Based Compensation
Restricted Stock Units
A summary of the Company’s restricted stock unit (“RSU”) activity and related information for the six months ended March 28, 2026, is as follows:
Number of
RSUs
(in thousands)
Weighted-Average
Grant-Date Fair
Value Per RSU
Balance as of September 27, 2025151,574 $189.75 
RSUs granted66,083 $256.04 
RSUs vested(37,502)$174.38 
RSUs forfeited(6,170)$210.31 
Balance as of March 28, 2026173,985 $217.51 
The total vesting-date fair value of RSUs was $917 million and $906 million for the three months ended March 28, 2026 and March 29, 2025, respectively, and was $9.5 billion and $9.3 billion for the six months ended March 28, 2026 and March 29, 2025, respectively.
Share-Based Compensation
The following table shows share-based compensation expense and the related income tax benefit included in the Condensed Consolidated Statements of Operations for the three- and six-month periods ended March 28, 2026 and March 29, 2025 (in millions):
Three Months EndedSix Months Ended
March 28,
2026
March 29,
2025
March 28,
2026
March 29,
2025
Share-based compensation expense$3,528 $3,226 $7,122 $6,512 
Income tax benefit related to share-based compensation expense$(802)$(743)$(2,095)$(2,075)
As of March 28, 2026, the total unrecognized compensation cost related to outstanding RSUs was $28.8 billion, which the Company expects to recognize over a weighted-average period of 2.8 years.
v3.26.1
Commitments and Contingencies
6 Months Ended
Mar. 28, 2026
Commitments and Contingencies Disclosure [Abstract]  
Commitments and Contingencies Commitments and Contingencies
Unconditional Purchase Obligations
The Company has entered into certain off–balance sheet commitments that require the future purchase of goods or services (“unconditional purchase obligations”). The Company’s unconditional purchase obligations primarily consist of supplier arrangements, distribution rights, and licensed intellectual property and content. Future payments under unconditional purchase obligations with a remaining term in excess of one year as of March 28, 2026, are as follows (in millions):
2026 (remaining six months)$2,994 
20277,343 
20286,130 
20295,394 
20305,281 
Thereafter549 
Total$27,691 
Contingencies
The Company is subject to various legal proceedings and claims that have arisen in the ordinary course of business and that have not been fully resolved. The outcome of litigation is inherently uncertain. In the opinion of management, there was not at least a reasonable possibility the Company may have incurred a material loss, or a material loss greater than a recorded accrual, concerning loss contingencies for asserted legal and other claims.
v3.26.1
Segment Information
6 Months Ended
Mar. 28, 2026
Segment Reporting [Abstract]  
Segment Information Segment Information
The following tables show information by reportable segment for the three- and six-month periods ended March 28, 2026 and March 29, 2025 (in millions):
Three Months Ended March 28, 2026
AmericasEurope
Greater
China
JapanRest of
Asia Pacific
CorporateTotal
Net sales$45,093 $28,055 $20,497 $8,401 $9,138 $— $111,184 
Cost of sales(23,114)(13,756)(10,633)(4,267)(4,633)— (56,403)
Research and development— — — — — (11,419)(11,419)
Selling and marketing(2,606)(1,247)(675)(295)(378)— (5,201)
General and administrative— — — — — (2,276)(2,276)
Operating income/(loss)$19,373 $13,052 $9,189 $3,839 $4,127 $(13,695)$35,885 
Three Months Ended March 29, 2025
AmericasEuropeGreater
China
JapanRest of
Asia Pacific
CorporateTotal
Net sales$40,315 $24,454 $16,002 $7,298 $7,290 $— $95,359 
Cost of sales(21,094)(13,025)(8,794)(3,610)(3,969)— (50,492)
Research and development— — — — — (8,550)(8,550)
Selling and marketing(2,447)(1,113)(582)(254)(335)— (4,731)
General and administrative— — — — — (1,997)(1,997)
Operating income/(loss)$16,774 $10,316 $6,626 $3,434 $2,986 $(10,547)$29,589 
Six Months Ended March 28, 2026
AmericasEurope
Greater
China
JapanRest of
Asia Pacific
CorporateTotal
Net sales$103,622 $66,201 $46,023 $17,814 $21,280 $— $254,940 
Cost of sales(54,963)(32,817)(23,663)(8,778)(10,707)— (130,928)
Research and development— — — — — (22,306)(22,306)
Selling and marketing(5,333)(2,542)(1,379)(584)(760)— (10,598)
General and administrative— — — — — (4,371)(4,371)
Operating income/(loss)$43,326 $30,842 $20,981 $8,452 $9,813 $(26,677)$86,737 
Six Months Ended March 29, 2025
AmericasEurope
Greater
China
JapanRest of
Asia Pacific
CorporateTotal
Net sales$92,963 $58,315 $34,515 $16,285 $17,581 $— $219,659 
Cost of sales(49,589)(31,068)(18,553)(8,003)(9,304)— (116,517)
Research and development— — — — — (16,818)(16,818)
Selling and marketing(5,091)(2,324)(1,176)(534)(707)— (9,832)
General and administrative— — — — — (4,071)(4,071)
Operating income/(loss)$38,283 $24,923 $14,786 $7,748 $7,570 $(20,889)$72,421 
v3.26.1
Insider Trading Arrangements
3 Months Ended
Mar. 28, 2026
shares
Trading Arrangements, by Individual  
Non-Rule 10b5-1 Arrangement Adopted false
Rule 10b5-1 Arrangement Terminated false
Non-Rule 10b5-1 Arrangement Terminated false
Ben Borders [Member]  
Trading Arrangements, by Individual  
Name Ben Borders
Title Principal Accounting Officer
Rule 10b5-1 Arrangement Adopted true
Adoption Date February 6, 2026
Expiration Date December 31, 2026
Arrangement Duration 329 days
Aggregate Available 898
v3.26.1
Summary of Significant Accounting Policies (Policies)
6 Months Ended
Mar. 28, 2026
Accounting Policies [Abstract]  
Basis of Presentation and Preparation
Basis of Presentation and Preparation
The condensed consolidated financial statements include the accounts of Apple Inc. and its wholly owned subsidiaries (collectively “Apple” or the “Company”). In the opinion of the Company’s management, the condensed consolidated financial statements reflect all adjustments, which are normal and recurring in nature, necessary for fair financial statement presentation. The preparation of these condensed consolidated financial statements and accompanying notes in conformity with U.S. generally accepted accounting principles (“GAAP”) requires the use of management estimates. Certain prior period amounts in the condensed consolidated financial statements and accompanying notes have been reclassified to conform to the current period’s presentation. These condensed consolidated financial statements and accompanying notes should be read in conjunction with the Company’s annual consolidated financial statements and accompanying notes included in its Annual Report on Form 10-K for the fiscal year ended September 27, 2025 (the “2025 Form 10-K”).
Fiscal Period
The Company’s fiscal year is the 52- or 53-week period that ends on the last Saturday of September. An additional week is included in the first fiscal quarter every five or six years to realign the Company’s fiscal quarters with calendar quarters. The Company’s fiscal years 2026 and 2025 span 52 weeks each. Unless otherwise stated, references to particular years, quarters, months and periods refer to the Company’s fiscal years ended in September and the associated quarters, months and periods of those fiscal years.
Fair Value Measurements The valuation techniques used to measure the fair values of the Company’s Level 2 financial instruments, which generally have counterparties with high credit ratings, are based on quoted market prices or model-driven valuations using significant inputs derived from or corroborated by observable market data.
v3.26.1
Revenue (Tables)
6 Months Ended
Mar. 28, 2026
Revenue from Contract with Customer [Abstract]  
Disaggregated Net Sales and Portion of Net Sales That Was Previously Deferred
The following table shows disaggregated net sales, as well as the portion of total net sales that was previously deferred, for the three- and six-month periods ended March 28, 2026 and March 29, 2025 (in millions):
Three Months EndedSix Months Ended
March 28,
2026
March 29,
2025
March 28,
2026
March 29,
2025
iPhone®
$56,994 $46,841 $142,263 $115,979 
Mac®
8,399 7,949 16,785 16,936 
iPad®
6,914 6,402 15,509 14,490 
Wearables, Home and Accessories7,901 7,522 19,394 19,269 
Services30,976 26,645 60,989 52,985 
Total net sales$111,184 $95,359 $254,940 $219,659 
Portion of total net sales that was included in deferred revenue as of the beginning of the period
$3,987 $3,672 $5,834 $5,440 
v3.26.1
Earnings Per Share (Tables)
6 Months Ended
Mar. 28, 2026
Earnings Per Share [Abstract]  
Computation of Basic and Diluted Earnings Per Share
The following table shows the computation of basic and diluted earnings per share for the three- and six-month periods ended March 28, 2026 and March 29, 2025 (net income in millions and shares in thousands):
Three Months EndedSix Months Ended
March 28,
2026
March 29,
2025
March 28,
2026
March 29,
2025
Numerator:
Net income$29,578 $24,780 $71,675 $61,110 
Denominator:
Weighted-average basic shares outstanding14,673,278 14,994,082 14,710,718 15,037,903 
Effect of dilutive share-based awards
52,595 62,051 57,397 65,596 
Weighted-average diluted shares14,725,873 15,056,133 14,768,115 15,103,499 
Basic earnings per share$2.02 $1.65 $4.87 $4.06 
Diluted earnings per share$2.01 $1.65 $4.85 $4.05 
v3.26.1
Financial Instruments (Tables)
6 Months Ended
Mar. 28, 2026
Financial Instruments [Abstract]  
Cash, Cash Equivalents and Marketable Securities by Significant Investment Category
The following tables show the Company’s cash, cash equivalents and marketable securities by significant investment category as of March 28, 2026 and September 27, 2025 (in millions):
March 28, 2026
Adjusted
Cost
Unrealized
Gains
Unrealized
Losses
Fair
Value
Cash and
Cash
Equivalents
Current
Marketable
Securities
Non-Current
Marketable
Securities
Cash$29,740 $— $— $29,740 $29,740 $— $— 
Level 1:
Money market funds6,588 — — 6,588 6,588 — — 
Mutual funds
821 128 (14)935 — 935 — 
Subtotal7,409 128 (14)7,523 6,588 935 — 
Level 2 (1):
U.S. Treasury securities18,650 14 (254)18,410 2,935 4,174 11,301 
U.S. agency securities7,483 — (112)7,371 2,923 2,470 1,978 
Non-U.S. government securities5,906 45 (493)5,458 — 576 4,882 
Certificates of deposit and time deposits3,263 — — 3,263 2,987 276 — 
Commercial paper3,628 — — 3,628 399 3,229 — 
Corporate debt securities48,111 83 (982)47,212 — 11,042 36,170 
Municipal securities122 — (1)121 — 95 26 
Mortgage- and asset-backed securities25,106 64 (1,301)23,869 — 138 23,731 
Subtotal112,269 206 (3,143)109,332 9,244 22,000 78,088 
Total
$149,418 $334 $(3,157)$146,595 $45,572 $22,935 $78,088 
September 27, 2025
Adjusted
Cost
Unrealized
Gains
Unrealized
Losses
Fair
Value
Cash and
Cash
Equivalents
Current
Marketable
Securities
Non-Current
Marketable
Securities
Cash$28,267 $— $— $28,267 $28,267 $— $— 
Level 1:
Money market funds5,272 — — 5,272 5,272 — — 
Mutual funds
679 177 (2)854 — 854 — 
Subtotal5,951 177 (2)6,126 5,272 854 — 
Level 2 (1):
U.S. Treasury securities16,074 56 (282)15,848 1,190 3,712 10,946 
U.S. agency securities5,269 — (149)5,120 251 2,456 2,413 
Non-U.S. government securities6,586 111 (424)6,273 — 855 5,418 
Certificates of deposit and time deposits917 — — 917 904 — 13 
Commercial paper100 — — 100 50 50 — 
Corporate debt securities47,210 266 (916)46,560 — 10,623 35,937 
Municipal securities207 — (2)205 — 119 86 
Mortgage- and asset-backed securities24,130 126 (1,252)23,004 — 94 22,910 
Subtotal100,493 559 (3,025)98,027 2,395 17,909 77,723 
Total
$134,711 $736 $(3,027)$132,420 $35,934 $18,763 $77,723 
(1)The valuation techniques used to measure the fair values of the Company’s Level 2 financial instruments, which generally have counterparties with high credit ratings, are based on quoted market prices or model-driven valuations using significant inputs derived from or corroborated by observable market data.
Notional Amounts of Outstanding Derivative Instruments
The notional amounts of the Company’s outstanding derivative instruments as of March 28, 2026 and September 27, 2025, were as follows (in millions):
March 28,
2026
September 27,
2025
Derivative instruments designated as accounting hedges:
Foreign exchange contracts$57,963 $62,647 
Interest rate contracts$10,625 $12,875 
Derivative instruments not designated as accounting hedges:
Foreign exchange contracts$96,341 $109,079 
v3.26.1
Condensed Consolidated Financial Statement Details (Tables)
6 Months Ended
Mar. 28, 2026
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Property, Plant and Equipment, Net
Property, Plant and Equipment, Net
March 28,
2026
September 27,
2025
Gross property, plant and equipment$127,557 $125,848 
Accumulated depreciation
(77,441)(76,014)
Total property, plant and equipment, net$50,116 $49,834 
Intangible Assets, Net
Intangible Assets, Net
March 28,
2026
September 27,
2025
Gross intangible assets$37,767 $24,950 
Accumulated amortization(11,970)(11,649)
Total intangible assets, net25,797 13,301 
Less: Current portion of intangible assets, net(4,463)(2,208)
Non-current portion of intangible assets, net$21,334 $11,093 
v3.26.1
Debt (Tables)
6 Months Ended
Mar. 28, 2026
Debt Disclosure [Abstract]  
Summary of Cash Flows Associated with Commercial Paper The following table provides a summary of cash flows associated with commercial paper for the six months ended March 28, 2026 and March 29, 2025 (in millions):
Six Months Ended
March 28,
2026
March 29,
2025
Maturities 90 days or less:
Repayments of commercial paper, net$(2,123)$(3,968)
Maturities greater than 90 days:
Repayments of commercial paper(3,788)— 
Total repayments of commercial paper, net$(5,911)$(3,968)
v3.26.1
Share-Based Compensation (Tables)
6 Months Ended
Mar. 28, 2026
Share-Based Payment Arrangement [Abstract]  
Restricted Stock Unit Activity
A summary of the Company’s restricted stock unit (“RSU”) activity and related information for the six months ended March 28, 2026, is as follows:
Number of
RSUs
(in thousands)
Weighted-Average
Grant-Date Fair
Value Per RSU
Balance as of September 27, 2025151,574 $189.75 
RSUs granted66,083 $256.04 
RSUs vested(37,502)$174.38 
RSUs forfeited(6,170)$210.31 
Balance as of March 28, 2026173,985 $217.51 
Share-Based Compensation Expense and the Related Income Tax Benefit
The following table shows share-based compensation expense and the related income tax benefit included in the Condensed Consolidated Statements of Operations for the three- and six-month periods ended March 28, 2026 and March 29, 2025 (in millions):
Three Months EndedSix Months Ended
March 28,
2026
March 29,
2025
March 28,
2026
March 29,
2025
Share-based compensation expense$3,528 $3,226 $7,122 $6,512 
Income tax benefit related to share-based compensation expense$(802)$(743)$(2,095)$(2,075)
v3.26.1
Commitments and Contingencies (Tables)
6 Months Ended
Mar. 28, 2026
Commitments and Contingencies Disclosure [Abstract]  
Future Payments Under Unconditional Purchase Obligations Future payments under unconditional purchase obligations with a remaining term in excess of one year as of March 28, 2026, are as follows (in millions):
2026 (remaining six months)$2,994 
20277,343 
20286,130 
20295,394 
20305,281 
Thereafter549 
Total$27,691 
v3.26.1
Segment Information (Tables)
6 Months Ended
Mar. 28, 2026
Segment Reporting [Abstract]  
Information by Reportable Segment
The following tables show information by reportable segment for the three- and six-month periods ended March 28, 2026 and March 29, 2025 (in millions):
Three Months Ended March 28, 2026
AmericasEurope
Greater
China
JapanRest of
Asia Pacific
CorporateTotal
Net sales$45,093 $28,055 $20,497 $8,401 $9,138 $— $111,184 
Cost of sales(23,114)(13,756)(10,633)(4,267)(4,633)— (56,403)
Research and development— — — — — (11,419)(11,419)
Selling and marketing(2,606)(1,247)(675)(295)(378)— (5,201)
General and administrative— — — — — (2,276)(2,276)
Operating income/(loss)$19,373 $13,052 $9,189 $3,839 $4,127 $(13,695)$35,885 
Three Months Ended March 29, 2025
AmericasEuropeGreater
China
JapanRest of
Asia Pacific
CorporateTotal
Net sales$40,315 $24,454 $16,002 $7,298 $7,290 $— $95,359 
Cost of sales(21,094)(13,025)(8,794)(3,610)(3,969)— (50,492)
Research and development— — — — — (8,550)(8,550)
Selling and marketing(2,447)(1,113)(582)(254)(335)— (4,731)
General and administrative— — — — — (1,997)(1,997)
Operating income/(loss)$16,774 $10,316 $6,626 $3,434 $2,986 $(10,547)$29,589 
Six Months Ended March 28, 2026
AmericasEurope
Greater
China
JapanRest of
Asia Pacific
CorporateTotal
Net sales$103,622 $66,201 $46,023 $17,814 $21,280 $— $254,940 
Cost of sales(54,963)(32,817)(23,663)(8,778)(10,707)— (130,928)
Research and development— — — — — (22,306)(22,306)
Selling and marketing(5,333)(2,542)(1,379)(584)(760)— (10,598)
General and administrative— — — — — (4,371)(4,371)
Operating income/(loss)$43,326 $30,842 $20,981 $8,452 $9,813 $(26,677)$86,737 
Six Months Ended March 29, 2025
AmericasEurope
Greater
China
JapanRest of
Asia Pacific
CorporateTotal
Net sales$92,963 $58,315 $34,515 $16,285 $17,581 $— $219,659 
Cost of sales(49,589)(31,068)(18,553)(8,003)(9,304)— (116,517)
Research and development— — — — — (16,818)(16,818)
Selling and marketing(5,091)(2,324)(1,176)(534)(707)— (9,832)
General and administrative— — — — — (4,071)(4,071)
Operating income/(loss)$38,283 $24,923 $14,786 $7,748 $7,570 $(20,889)$72,421 
v3.26.1
Revenue - Disaggregated Net Sales and Portion of Net Sales That Was Previously Deferred (Details) - USD ($)
$ in Millions
3 Months Ended 6 Months Ended
Mar. 28, 2026
Mar. 29, 2025
Mar. 28, 2026
Mar. 29, 2025
Disaggregation of Revenue [Line Items]        
Net sales $ 111,184 $ 95,359 $ 254,940 $ 219,659
Portion of total net sales that was included in deferred revenue as of the beginning of the period 3,987 3,672 5,834 5,440
iPhone        
Disaggregation of Revenue [Line Items]        
Net sales 56,994 46,841 142,263 115,979
Mac        
Disaggregation of Revenue [Line Items]        
Net sales 8,399 7,949 16,785 16,936
iPad        
Disaggregation of Revenue [Line Items]        
Net sales 6,914 6,402 15,509 14,490
Wearables, Home and Accessories        
Disaggregation of Revenue [Line Items]        
Net sales 7,901 7,522 19,394 19,269
Services        
Disaggregation of Revenue [Line Items]        
Net sales $ 30,976 $ 26,645 $ 60,989 $ 52,985
v3.26.1
Revenue - Additional Information (Details) - USD ($)
$ in Billions
Mar. 28, 2026
Sep. 27, 2025
Revenue from Contract with Customer [Abstract]    
Total deferred revenue $ 14.7 $ 13.7
v3.26.1
Revenue - Deferred Revenue, Expected Timing of Realization (Details)
Mar. 28, 2026
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2026-03-29  
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]  
Deferred revenue, expected timing of realization, percentage 64.00%
Deferred revenue, expected timing of realization, period 1 year
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2027-03-28  
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]  
Deferred revenue, expected timing of realization, percentage 23.00%
Deferred revenue, expected timing of realization, period 1 year
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2028-04-02  
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]  
Deferred revenue, expected timing of realization, percentage 11.00%
Deferred revenue, expected timing of realization, period 1 year
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2029-04-01  
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]  
Deferred revenue, expected timing of realization, percentage 2.00%
Deferred revenue, expected timing of realization, period 1 year
v3.26.1
Earnings Per Share - Computation of Basic and Diluted Earnings Per Share (Details) - USD ($)
$ / shares in Units, shares in Thousands, $ in Millions
3 Months Ended 6 Months Ended
Mar. 28, 2026
Mar. 29, 2025
Mar. 28, 2026
Mar. 29, 2025
Numerator:        
Net income $ 29,578 $ 24,780 $ 71,675 $ 61,110
Denominator:        
Weighted-average basic shares outstanding (in shares) 14,673,278 14,994,082 14,710,718 15,037,903
Effect of dilutive share-based awards (in shares) 52,595 62,051 57,397 65,596
Weighted-average diluted shares (in shares) 14,725,873 15,056,133 14,768,115 15,103,499
Basic earnings per share (in dollars per share) $ 2.02 $ 1.65 $ 4.87 $ 4.06
Diluted earnings per share (in dollars per share) $ 2.01 $ 1.65 $ 4.85 $ 4.05
v3.26.1
Financial Instruments - Cash, Cash Equivalents and Marketable Securities (Details) - USD ($)
$ in Millions
Mar. 28, 2026
Sep. 27, 2025
Marketable Securities [Line Items]    
Cash, Cash Equivalents and Marketable Securities, Adjusted Cost $ 149,418 $ 134,711
Cash Equivalents and Marketable Securities, Unrealized Gains 334 736
Cash Equivalents and Marketable Securities, Unrealized Losses (3,157) (3,027)
Cash, Cash Equivalents and Marketable Securities, Fair Value 146,595 132,420
Cash and Cash Equivalents 45,572 35,934
Current Marketable Securities 22,935 18,763
Non-Current
Marketable
Securities 78,088 77,723
Level 1    
Marketable Securities [Line Items]    
Marketable Securities, Equity, Adjusted Cost 7,409 5,951
Marketable Securities, Equity, Unrealized Gains 128 177
Marketable Securities, Equity, Unrealized Losses (14) (2)
Marketable Securities, Equity, Fair Value 7,523 6,126
Cash and Cash Equivalents 6,588 5,272
Current Marketable Securities 935 854
Non-Current
Marketable
Securities 0 0
Level 2    
Marketable Securities [Line Items]    
Marketable Securities, Debt, Adjusted Cost 112,269 100,493
Marketable Securities, Debt, Unrealized Gains 206 559
Marketable Securities, Debt, Unrealized Losses (3,143) (3,025)
Marketable Securities, Debt, Fair Value 109,332 98,027
Cash and Cash Equivalents 9,244 2,395
Current Marketable Securities 22,000 17,909
Non-Current
Marketable
Securities 78,088 77,723
Cash    
Marketable Securities [Line Items]    
Cash 29,740 28,267
Cash and Cash Equivalents 29,740 28,267
Money market funds | Level 1    
Marketable Securities [Line Items]    
Marketable Securities, Equity, Adjusted Cost 6,588 5,272
Marketable Securities, Equity, Unrealized Gains 0 0
Marketable Securities, Equity, Unrealized Losses 0 0
Marketable Securities, Equity, Fair Value 6,588 5,272
Cash and Cash Equivalents 6,588 5,272
Current Marketable Securities 0 0
Non-Current
Marketable
Securities 0 0
Mutual funds | Level 1    
Marketable Securities [Line Items]    
Marketable Securities, Equity, Adjusted Cost 821 679
Marketable Securities, Equity, Unrealized Gains 128 177
Marketable Securities, Equity, Unrealized Losses (14) (2)
Marketable Securities, Equity, Fair Value 935 854
Cash and Cash Equivalents 0 0
Current Marketable Securities 935 854
Non-Current
Marketable
Securities 0 0
U.S. Treasury securities | Level 2    
Marketable Securities [Line Items]    
Marketable Securities, Debt, Adjusted Cost 18,650 16,074
Marketable Securities, Debt, Unrealized Gains 14 56
Marketable Securities, Debt, Unrealized Losses (254) (282)
Marketable Securities, Debt, Fair Value 18,410 15,848
Cash and Cash Equivalents 2,935 1,190
Current Marketable Securities 4,174 3,712
Non-Current
Marketable
Securities 11,301 10,946
U.S. agency securities | Level 2    
Marketable Securities [Line Items]    
Marketable Securities, Debt, Adjusted Cost 7,483 5,269
Marketable Securities, Debt, Unrealized Gains 0 0
Marketable Securities, Debt, Unrealized Losses (112) (149)
Marketable Securities, Debt, Fair Value 7,371 5,120
Cash and Cash Equivalents 2,923 251
Current Marketable Securities 2,470 2,456
Non-Current
Marketable
Securities 1,978 2,413
Non-U.S. government securities | Level 2    
Marketable Securities [Line Items]    
Marketable Securities, Debt, Adjusted Cost 5,906 6,586
Marketable Securities, Debt, Unrealized Gains 45 111
Marketable Securities, Debt, Unrealized Losses (493) (424)
Marketable Securities, Debt, Fair Value 5,458 6,273
Cash and Cash Equivalents 0 0
Current Marketable Securities 576 855
Non-Current
Marketable
Securities 4,882 5,418
Certificates of deposit and time deposits | Level 2    
Marketable Securities [Line Items]    
Marketable Securities, Debt, Adjusted Cost 3,263 917
Marketable Securities, Debt, Unrealized Gains 0 0
Marketable Securities, Debt, Unrealized Losses 0 0
Marketable Securities, Debt, Fair Value 3,263 917
Cash and Cash Equivalents 2,987 904
Current Marketable Securities 276 0
Non-Current
Marketable
Securities 0 13
Commercial paper | Level 2    
Marketable Securities [Line Items]    
Marketable Securities, Debt, Adjusted Cost 3,628 100
Marketable Securities, Debt, Unrealized Gains 0 0
Marketable Securities, Debt, Unrealized Losses 0 0
Marketable Securities, Debt, Fair Value 3,628 100
Cash and Cash Equivalents 399 50
Current Marketable Securities 3,229 50
Non-Current
Marketable
Securities 0 0
Corporate debt securities | Level 2    
Marketable Securities [Line Items]    
Marketable Securities, Debt, Adjusted Cost 48,111 47,210
Marketable Securities, Debt, Unrealized Gains 83 266
Marketable Securities, Debt, Unrealized Losses (982) (916)
Marketable Securities, Debt, Fair Value 47,212 46,560
Cash and Cash Equivalents 0 0
Current Marketable Securities 11,042 10,623
Non-Current
Marketable
Securities 36,170 35,937
Municipal securities | Level 2    
Marketable Securities [Line Items]    
Marketable Securities, Debt, Adjusted Cost 122 207
Marketable Securities, Debt, Unrealized Gains 0 0
Marketable Securities, Debt, Unrealized Losses (1) (2)
Marketable Securities, Debt, Fair Value 121 205
Cash and Cash Equivalents 0 0
Current Marketable Securities 95 119
Non-Current
Marketable
Securities 26 86
Mortgage- and asset-backed securities | Level 2    
Marketable Securities [Line Items]    
Marketable Securities, Debt, Adjusted Cost 25,106 24,130
Marketable Securities, Debt, Unrealized Gains 64 126
Marketable Securities, Debt, Unrealized Losses (1,301) (1,252)
Marketable Securities, Debt, Fair Value 23,869 23,004
Cash and Cash Equivalents 0 0
Current Marketable Securities 138 94
Non-Current
Marketable
Securities $ 23,731 $ 22,910
v3.26.1
Financial Instruments - Additional Information (Details)
$ in Billions
6 Months Ended 12 Months Ended
Mar. 28, 2026
USD ($)
Vendor
Customer
Sep. 27, 2025
USD ($)
Vendor
Customer
Debt Securities, Available-for-Sale, Maturity, Fair Value, Rolling Maturity [Abstract]    
Carrying amount of hedged term debt | $ $ 10.4 $ 12.6
Hedged liability, statement of financial position [Extensible Enumeration] Term debt, Term debt Term debt, Term debt
Trade receivables | Credit concentration risk    
Debt Securities, Available-for-Sale, Maturity, Fair Value, Rolling Maturity [Abstract]    
Number of customers that individually represented 10% or more of total trade receivables | Customer 1 1
Trade receivables | Credit concentration risk | Customer one    
Debt Securities, Available-for-Sale, Maturity, Fair Value, Rolling Maturity [Abstract]    
Concentration risk, percentage 17.00% 12.00%
Trade receivables | Credit concentration risk | Cellular network carriers    
Debt Securities, Available-for-Sale, Maturity, Fair Value, Rolling Maturity [Abstract]    
Concentration risk, percentage 30.00% 34.00%
Non-trade receivables | Credit concentration risk    
Debt Securities, Available-for-Sale, Maturity, Fair Value, Rolling Maturity [Abstract]    
Number of vendors that individually represented 10% or more of total vendor non-trade receivables | Vendor 2 2
Non-trade receivables | Credit concentration risk | Vendor one    
Debt Securities, Available-for-Sale, Maturity, Fair Value, Rolling Maturity [Abstract]    
Concentration risk, percentage 51.00% 46.00%
Non-trade receivables | Credit concentration risk | Vendor two    
Debt Securities, Available-for-Sale, Maturity, Fair Value, Rolling Maturity [Abstract]    
Concentration risk, percentage 18.00% 23.00%
Hedges of foreign currency exposure associated with revenue and inventory purchases    
Debt Securities, Available-for-Sale, Maturity, Fair Value, Rolling Maturity [Abstract]    
Maximum length of time over which the Company is hedging its exposure to the variability in future cash flows for foreign currency transactions 12 months  
Hedges of foreign currency exposure associated with term debt    
Debt Securities, Available-for-Sale, Maturity, Fair Value, Rolling Maturity [Abstract]    
Maximum length of time over which the Company is hedging its exposure to the variability in future cash flows for foreign currency transactions 16 years  
Marketable debt securities other than mortgage- and asset-backed securities    
Debt Securities, Available-for-Sale, Maturity, Fair Value, Rolling Maturity [Abstract]    
Between 1 and 5 years 79.00%  
Between 5 and 10 years 17.00%  
Greater than 10 years 4.00%  
Mortgage- and asset-backed securities    
Debt Securities, Available-for-Sale, Maturity, Fair Value, Rolling Maturity [Abstract]    
Between 1 and 5 years 13.00%  
Between 5 and 10 years 22.00%  
Greater than 10 years 65.00%  
v3.26.1
Financial Instruments - Notional Amounts of Derivative Instruments (Details) - USD ($)
$ in Millions
Mar. 28, 2026
Sep. 27, 2025
Derivatives designated as accounting hedges | Foreign exchange contracts    
Derivatives, Fair Value [Line Items]    
Derivatives, notional amount $ 57,963 $ 62,647
Derivatives designated as accounting hedges | Interest rate contracts    
Derivatives, Fair Value [Line Items]    
Derivatives, notional amount 10,625 12,875
Derivatives not designated as accounting hedges | Foreign exchange contracts    
Derivatives, Fair Value [Line Items]    
Derivatives, notional amount $ 96,341 $ 109,079
v3.26.1
Condensed Consolidated Financial Statement Details - Property, Plant and Equipment, Net (Details) - USD ($)
$ in Millions
Mar. 28, 2026
Sep. 27, 2025
Organization, Consolidation and Presentation of Financial Statements [Abstract]    
Gross property, plant and equipment $ 127,557 $ 125,848
Accumulated depreciation (77,441) (76,014)
Total property, plant and equipment, net $ 50,116 $ 49,834
v3.26.1
Condensed Consolidated Financial Statement Details - Intangible Assets, Net (Details) - USD ($)
$ in Millions
Mar. 28, 2026
Sep. 27, 2025
Organization, Consolidation and Presentation of Financial Statements [Abstract]    
Gross intangible assets $ 37,767 $ 24,950
Accumulated amortization 11,970 11,649
Total intangible assets, net 25,797 13,301
Less: Current portion of intangible assets, net (4,463) (2,208)
Non-current portion of intangible assets, net $ 21,334 $ 11,093
v3.26.1
Debt - Additional Information (Details) - USD ($)
$ in Millions
Mar. 28, 2026
Sep. 27, 2025
Debt Instrument [Line Items]    
Commercial paper $ 1,997 $ 7,979
Fixed-rate notes, aggregate carrying amount 82,700 90,700
Commercial paper    
Debt Instrument [Line Items]    
Commercial paper 2,000 8,000
Level 2    
Debt Instrument [Line Items]    
Fixed-rate notes, aggregate fair value $ 70,800 $ 80,400
v3.26.1
Debt - Summary of Cash Flows Associated with Commercial Paper (Details) - USD ($)
$ in Millions
6 Months Ended
Mar. 28, 2026
Mar. 29, 2025
Maturities 90 days or less:    
Repayments of commercial paper, net $ (2,123) $ (3,968)
Maturities greater than 90 days:    
Repayments of commercial paper (3,788) 0
Total repayments of commercial paper, net $ (5,911) $ (3,968)
v3.26.1
Shareholders' Equity - Additional Information (Details)
shares in Millions, $ in Billions
6 Months Ended
Mar. 28, 2026
USD ($)
shares
Stockholders' Equity Note [Abstract]  
Number of shares repurchased (in shares) | shares 135
Amount of share repurchases | $ $ 36.0
v3.26.1
Share-Based Compensation - Restricted Stock Unit Activity and Related Information (Details) - Restricted stock units
shares in Thousands
6 Months Ended
Mar. 28, 2026
$ / shares
shares
Number of Restricted Stock Units  
Beginning balance (in shares) | shares 151,574
RSUs granted (in shares) | shares 66,083
RSUs vested (in shares) | shares (37,502)
RSUs forfeited (in shares) | shares (6,170)
Ending balance (in shares) | shares 173,985
Weighted-Average Grant-Date Fair Value Per RSU  
Beginning balance (in dollars per share) | $ / shares $ 189.75
RSUs granted (in dollars per share) | $ / shares 256.04
RSUs vested (in dollars per share) | $ / shares 174.38
RSUs forfeited (in dollars per share) | $ / shares 210.31
Ending balance (in dollars per share) | $ / shares $ 217.51
v3.26.1
Share-Based Compensation - Additional Information (Details) - Restricted stock units - USD ($)
$ in Millions
3 Months Ended 6 Months Ended
Mar. 28, 2026
Mar. 29, 2025
Mar. 28, 2026
Mar. 29, 2025
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Total vesting-date fair value of RSUs $ 917 $ 906 $ 9,500 $ 9,300
Total unrecognized compensation cost related to outstanding RSUs $ 28,800   $ 28,800  
Total unrecognized compensation cost related to outstanding RSUs, weighted-average recognition period     2 years 9 months 18 days  
v3.26.1
Share-Based Compensation - Summary of Share-Based Compensation Expense and the Related Income Tax Benefit (Details) - USD ($)
$ in Millions
3 Months Ended 6 Months Ended
Mar. 28, 2026
Mar. 29, 2025
Mar. 28, 2026
Mar. 29, 2025
Share-Based Payment Arrangement [Abstract]        
Share-based compensation expense $ 3,528 $ 3,226 $ 7,122 $ 6,512
Income tax benefit related to share-based compensation expense $ (802) $ (743) $ (2,095) $ (2,075)
v3.26.1
Commitments and Contingencies - Future Payments Under Unconditional Purchase Obligations (Details)
$ in Millions
Mar. 28, 2026
USD ($)
Unconditional Purchase Obligation, Fiscal Year Maturity [Abstract]  
2026 (remaining six months) $ 2,994
2027 7,343
2028 6,130
2029 5,394
2030 5,281
Thereafter 549
Total $ 27,691
v3.26.1
Segment Information - Additional Information (Details)
6 Months Ended
Mar. 28, 2026
Segment Reporting [Abstract]  
Number of reportable segments not disclosed flag true
v3.26.1
Segment Information - Information by Reportable Segment (Details) - USD ($)
$ in Millions
3 Months Ended 6 Months Ended
Mar. 28, 2026
Mar. 29, 2025
Mar. 28, 2026
Mar. 29, 2025
Segment Reporting Information [Line Items]        
Net sales $ 111,184 $ 95,359 $ 254,940 $ 219,659
Cost of sales (56,403) (50,492) (130,928) (116,517)
Research and development (11,419) (8,550) (22,306) (16,818)
Selling and marketing (5,201) (4,731) (10,598) (9,832)
General and administrative (2,276) (1,997) (4,371) (4,071)
Operating income 35,885 29,589 86,737 72,421
Corporate non-segment        
Segment Reporting Information [Line Items]        
Research and development (11,419) (8,550) (22,306) (16,818)
General and administrative (2,276) (1,997) (4,371) (4,071)
Operating income (13,695) (10,547) (26,677) (20,889)
Americas | Operating segments        
Segment Reporting Information [Line Items]        
Net sales 45,093 40,315 103,622 92,963
Cost of sales (23,114) (21,094) (54,963) (49,589)
Selling and marketing (2,606) (2,447) (5,333) (5,091)
Operating income 19,373 16,774 43,326 38,283
Europe | Operating segments        
Segment Reporting Information [Line Items]        
Net sales 28,055 24,454 66,201 58,315
Cost of sales (13,756) (13,025) (32,817) (31,068)
Selling and marketing (1,247) (1,113) (2,542) (2,324)
Operating income 13,052 10,316 30,842 24,923
Greater China | Operating segments        
Segment Reporting Information [Line Items]        
Net sales 20,497 16,002 46,023 34,515
Cost of sales (10,633) (8,794) (23,663) (18,553)
Selling and marketing (675) (582) (1,379) (1,176)
Operating income 9,189 6,626 20,981 14,786
Japan | Operating segments        
Segment Reporting Information [Line Items]        
Net sales 8,401 7,298 17,814 16,285
Cost of sales (4,267) (3,610) (8,778) (8,003)
Selling and marketing (295) (254) (584) (534)
Operating income 3,839 3,434 8,452 7,748
Rest of Asia Pacific | Operating segments        
Segment Reporting Information [Line Items]        
Net sales 9,138 7,290 21,280 17,581
Cost of sales (4,633) (3,969) (10,707) (9,304)
Selling and marketing (378) (335) (760) (707)
Operating income $ 4,127 $ 2,986 $ 9,813 $ 7,570